Clinical Trial Update: Assessment of Treatment Response Using PET/CT Scanner - Non Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the use of PET/CT imaging to assess treatment response in Non-Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: University Health Network, Toronto | Conditions: Lymphoma, Non-Hodgkin | Phase 2 | Status: COMPLETED